Some thoughts on risk perception/risk communication in light of this week's @EMA_News statement on the possible link between the AZ #COVID19 vaccine & rare blood clots. A thread 🧵
Low probability, high consequence events are called dread risks. pure.mpg.de/rest/items/ite… There is a risk in avoiding risk. People can make decisions to avoid a rare risk that put them at a greater risk of a more common adverse outcome.
We don't know right now if the observed association between the vaccine and very rare clotting/bleeding issues is causal or if there may be some underlying factor involved. We don't know the baseline risk of these events in the context of the pandemic.
A key message for the potentially hesitant member of the public is the 1st point in the EMA statement- benefits of vaccination outweigh potential risks. The vaccine will likely prevent huge numbers of clots that would otherwise be caused by COVID.
People will have legitimate questions around what the EMA mean by very rare. We don't have solid estimates yet of the exact incidence, but based on evidence to date around 1 in a million would be a reasonable estimate- this may vary as more evidence emerges.
There are good principles of how to communicate evidence to patients dtb.bmj.com/content/57/8/1… Some key elements are: use numbers rather than words, always use a graphic when you can, use absolute rather than relative risk, use a consistent denominator when describing events.
I really like one of their examples where a scale with verbal and numeric descriptions contrasts everyday and clinical risks (examples here from the context of obstetric anaesthesia).
I have used graphics to visualise rare events in the context of medicines use in pregnancy and there is potential to apply this to the data on the possible association between the AZ vaccine and rare haematological outcomes
It is difficult to apply this though as the reported rates are so rare. As an example, this is what 1 in 100,000 looks like. You'll need to click on the image to see the 1 red square.
We could also think in terms of large crowds that people can visualise- 1 person in 12 All Ireland Final crowds in Croke Park
1 person in 77 fully standing concerts in the Three Arena
1 person in 19 Rugby International crowds in the Aviva Stadium
Finally- we could compare to other rare events. Fatalities in car crashes happened at a rate of 30 per million in 2020. Murders happened at a rate of 11 per million in 2019.
To summarise- these adverse effects may have a cause other than the vaccine and they are very rare. I would be happy to take the AZ vaccine. I would like my family to have access to it. If we want to end COVID, we need to use everything at our disposal. #VaccinesSaveLives
• • •
Missing some Tweet in this thread? You can try to
force a refresh
This tweet (especially the graph below-definitely a feasible outcome) is gravely concerning as we think about the 4th wave. Imagine the scenario in October where we’re looking back on this carnage & wondering where it went wrong. A few things that I think we would regret:
There was interprofessional sniping within the vaccination programme with vested interests arguing that they’re the best at vaccination instead of pooling skills and resources to maximise vaccine coverage.
There was no centralised continuous assessment of the optimal processes to maximise yield per vial, considering available consumables.
It is fantastic to see the #COVID19 vaccination programme begin #VaccinesSaveLives. Some initial thoughts for now & the weeks/months ahead (personal views): 1. All hands on deck approach in hospitals led to efficient systems vaccinating large numbers in a short space of time
2. True multidisciplinary working meant that expertise to solve problems & evolve the process was on hand 3. The hospital facilities that were used for this will have ~ 2 week lull before the second dose (accepting some delayed vaccines in between)
4. Mass vaccination centres won’t be set up over night so these suggestions focus on the next few weeks 5. Legislation is in place enabling a broad range of health professionals to vaccinate